Zurueck zur Suche

Reporte zur Charge U030590

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OR 4 CO 2 SD 1 AZ 1 CA 1 HI 1 ID 1

VAERS 2396446

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

mild
Staat
SD
Alter
5,0
Geschlecht
F
Eingang
29.07.2022
Impfdatum
25.07.2022
Beginn
25.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eye pruritus Lip pain Pruritus

Symptomtext

itchy eyes, gave dhist JR about and hour later, face itchy, lips hurt-gave zyrtec-symptoms improved July 28th: Her eyes are still bothering her. We have had to repeat the zyrtec yesterday which makes sense, usually I can get 2 days out of 5mg in my girls. She was up in the middle of the night saying they were super itchy. --July 29th: Eyes are still itchy, we almost had to fo another zyrtec last night but she powered through and fell asleep.-------------------------------------

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye pruritus
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
MTHFR genetic mutation
Vorgeschichte
-
Andere Medikamente
Daily Probiotic Cap Daily Value Multivitamin Tab Digestive Enzyme Cap Folet DHA oral, daily, fish oil and DHA liquid
Allergien
Penicillin = hives Erythromycin = red/swollen eye
Vorherige Impfungen
MMR

VAERS 2328241

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

mild
Staat
OR
Alter
-
Geschlecht
U
Eingang
23.06.2022
Impfdatum
23.05.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Drug ineffective Pyrexia

Symptomtext

lack of drug effect; diarrhea; fever; This spontaneous report was received from a consumer, concerning a 4-year-old patient of unknown gender. No information was provided regarding the patient's relevant medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies. On 23-MAY-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), at a dose of 0.5 milliliter (ml), once in the left thigh by subcutaneous route (lot number, which was verified to be a valid lot number, expiration date reported and upon internal validation established as 29-MAR-2023) and Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), 1 dosage form orally (lot number 1863317 is an invalid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ). Lot number 1863317 does not match any Company product as confirmed by Lot Verification team. The vaccines were administered as prophylaxis. On an unknown date, the patient experienced mild fever (pyrexia), diarrhea and lack of drug effect. At the time of the report, the outcome of the events was unknown. The causal relationship between events and the suspect vaccines was related, further described as "expected side effects of given vaccines". This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA003956:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2328238

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

mild
Staat
OR
Alter
0,6
Geschlecht
M
Eingang
23.06.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Drug ineffective Product administered to patient of inappropriate age Pyrexia Wrong product administered

Symptomtext

lack of drug effect; diarrhea; fever; Inappropriate age at vaccine administration; wrong vaccine administered; This spontaneous report was received from a consumer, concerning a 7-month-old male patient. No information was provided regarding the patient's relevant medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies. On 23-MAY-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), at a dose of 0.5 milliliter (ml), once in the left thigh by subcutaneous route (lot number, which was verified to be a valid lot number, expiration date reported and upon internal validation established as 29-MAR-2023) (product administered to patient of inappropriate age) and Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), 1 dosage form orally (lot number 1863317 is an invalid lot number for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ). Lot number 1863317 does not match any Company product as confirmed by Lot Verification team. Furthermore, it was reported the patient was supposed to be vaccinated with diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid (VAXELIS), but he received diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (QUADRACEL), at a dose of 0.5 ml, once in the left vastus lateralis by intramuscular route (lot number: C5970AA, expiration date not reported) instead (wrong product administered). All the vaccines were administered as prophylaxis. On an unknown date, the patient experienced mild fever (pyrexia), diarrhea and lack of drug effect. At the time of the report, the outcome of the events was unknown. The causality between the events and diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid (VAXELIS) was not related. The causal relationship between events and the remaining suspect vaccines was related, further described as "expected side effects of given vaccines". This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA006736:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2320408

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

mild
Staat
CO
Alter
4,0
Geschlecht
M
Eingang
15.06.2022
Impfdatum
13.06.2022
Beginn
14.06.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema

Symptomtext

Two days ago ( 6/13/22)pt. received his MMRV and DTap-IPV vaccines. Both were given in the left thigh. about 12 hour after administration of the vaccines mother noted 4-5cm area of redness around on his left thigh. The following morning (about 24 hours after the vaccines were given) the area of redness was much larger. Her photo shows an area of about 10x13 cm of redness. Today (48 hours after administration) the area of redness is even bigger. Discomfort is not worse. Mother gave him zyrtec but not sure if it did anything for him. He has complained of itching and irritation , he has no fever, not limping.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2636583

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
AZ
Alter
2,0
Geschlecht
F
Eingang
24.05.2023
Impfdatum
12.04.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

DTAP-IPV, MMRV WERE ADMINISTERED INADVERTEDLY.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
N/A
Allergien
-
Vorherige Impfungen
-

VAERS 2401351

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
04.08.2022
Impfdatum
04.08.2022
Beginn
04.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

Patient reports no symptoms at time of vaccinations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
patient advise to watch for side effects by Dr.
Aktuelle Erkrankungen
None at time of visit. Visit was on a medical assistant schedule.
Vorgeschichte
No, chronic or long-standing health conditions listed in the patients medical record.
Andere Medikamente
None at time of visit.
Allergien
No known allergies.
Vorherige Impfungen
-

VAERS 2359158

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
HI
Alter
1,0
Geschlecht
U
Eingang
06.07.2022
Impfdatum
22.06.2022
Beginn
22.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event

Symptomtext

No additional AE reported; Student medical assistant reports that a 12 month old patient was accidently administered both VARIVAX and PROQUAD on Jun 22. 2022.; This spontaneous report has been received from a student medical assistant concerning a 12-month-old patient of unknown gender. The concomitant medications, medical history, drug reactions or allergies, and concurrent conditions were not reported. On 22-JUN-2022, the patient was accidently administered both measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) lot # U030590, expiration date 29-MAR-2023 (strength, dose, route of administration and anatomical location were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) lot # U028164, expiration date 09-SEP-2023 (strength, dose, route of administration and anatomical location were not provided) for prophylaxis (accidental overdose). No further information was provided. Healthcare professional (HCP) provided consent to be followed up with, and stated if she was not there, could talk to anyone at the doctors' office. No additional adverse event (AE) was reported. No product quality complaints (PQC) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2345157

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
ID
Alter
50,0
Geschlecht
F
Eingang
30.06.2022
Impfdatum
28.05.2022
Beginn
28.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Pt was mistakenly given this MMRV and Adult Varicella on 5/28/22. I called Pt Pt 6/30/22 and she said she was very well and not having any problems from the shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2313607

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
OR
Alter
0,6
Geschlecht
U
Eingang
09.06.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE or PQC reported; PROQUAD was administered to 7 month old infant.; This spontaneous report has been received from a medical assistant concerning to a 7-month-old patient of unknown gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not provided. On 23-MAY-2022, the patient was administered a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) 0.5 mL, lot # U030590, expiration date 29-MAR-2023 (route of administration and anatomical location were not provided) as prophylaxis (product administered to patient of inappropriate age). No additional adverse event (AE) was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2290613

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
OR
Alter
0,6
Geschlecht
M
Eingang
23.05.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Product administration error

Symptomtext

administration error. Vaccine given prior to approved age. Proquad and Quadracel

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Pediatric Multivitamin w/ Fluoride
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2215888

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U030590

gering
Staat
CO
Alter
4,0
Geschlecht
F
Eingang
05.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Needle issue

Symptomtext

I roomed a 4 year old Patient at about 2:15 pm on 4/4/2022, who has had no vaccines in the past 2 years according to Mother of Patient. After the visit, the Provider instructed me to give 4-year-old vaccines. I prepared a Quadracel (DTaP, IPV) with a 1 inch 25-gauge needle to use intramuscularly and an MMRV (MMR, Varicella) with a 5/8-inch 25-gauge needle to use subcutaneously. This 5/8-inch needle has an orange safety mechanism and is commonly used for toddler subcutaneous vaccines. I identified the patient with full name and date of birth and gave the immunizations in the presence of Mother of Patient, who acknowledged that she observed the entire incident. Nothing was mentioned in the training that I received in the last 9 month about the Medical Hypodermic Needle-Pro 5/8-inch needles or any problems or issues that are unique to that particular needle type. When I began to give the immunizations, I started on the left arm with the subcutaneous MMRV. I cleaned the arm in a circular motion starting at the center working outward. I inserted the 5/8-inch needle into the back of the arm at a 45-degree angle. Then I pushed the 0.5 ml of fluid, at which point the needle separated from the orange safety mechanism and the fluid sprayed out on the Patient?s arm and ran down to the elbow, dripping on the bed. I picked up gauze that I had prepared. I removed the needle that was still inserted in Patient?s arm and cleaned fluid off the arm with the gauze. I apologized to the Mother of Patient and explained that the needle failed to inject that immunization and she acknowledged that she saw the issue occur and noticed that the fluid all sprayed onto the exterior of arm. I applied bandage to the site. I went to the right arm and cleaned the area properly, then injected the DTaP/IPV intramuscularly with the 1-inch needle without incident. Then informed the Mother of Patient that I need to consult with the Provider and Immunization Coordinator regarding what to do about the failed immunization. Mother of Patient acknowledged that she understands, did not appear to be upset and was cooperative. I left the room and noticed that my Lead MA, was speaking to Immunization Coordinator in the Pod, where we were located this day. I explained to them what occurred. They inquired if any of the fluid went into the arm of Patient. I stated that none of the MMRV went through the needle. This was also obvious because the arm was so wet and dripping fluid and only 0.5 ml of fluid was inside the syringe. I explained that Mother of Patient observed the incident and also did not observe any of the fluid entering the arm. Coordinator instructed me to wait until she could speak to another Immunization Coordinator. Coordinator returned to the Pod and informed me that I should draw up a new dose of MMRV and deliver the dose properly into the Patient?s arm. She also informed me that an Incident report will need to be filed also. I tightened the needle onto the orange safety device this time to make sure it is secure and not going to pop off again when I push the fluid this time. I went back into the room and the Patient is now upset that she has to get another injection. Mother of Patient held the Patient securely this time since Patient was not as cooperative and I cleaned the area properly again on the left arm about half an inch away from previous time. I inserted the needle at a 45-degree angle subcutaneously and pushed the plunger on the syringe. This time the fluid properly inserted into the Patient?s arm as expected. Patient tolerated the injection well and had no adverse reaction. Patient was upset at getting injection this time but calmed down to look at a variety of stickers soon afterwards. She repeatedly said, ?I don?t like this.? Mother of Patient soothed her and promised her an outing to get ice cream. Mother of Patient was not upset about incident and was cooperative with holding Patient to administer the second time. I explained the entire incident to the Provider who agreed with plan to administer a full dose since the first dose did not enter the needle. I completed VAERS report and incident report on 4/5/2022 regarding this incident.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Needle issue
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-